Regulation of Pituitary Gene Expression by Adrenalectomy

[1]  L. Fernand,et al.  Prostate‐Specific genes and their regulation by dihydrotestosterone , 2008, The Prostate.

[2]  Y. Nishida,et al.  Regulation of hypothalamic gene expression by glucocorticoid: implications for energy homeostasis. , 2006, Physiological genomics.

[3]  A. Kubosaki,et al.  Disruption of the transmembrane dense core vesicle proteins IA-2 and IA-2beta causes female infertility. , 2006, Endocrinology.

[4]  K. Renner,et al.  Local inhibition of organic cation transporters increases extracellular serotonin in the medial hypothalamus , 2005, Brain Research.

[5]  E. Ur,et al.  Pituitary Resistin Gene Expression Is Upregulated in vitro and in vivo by Dexamethasone but Is Unaffected by Rosiglitazone , 2005, Neuroendocrinology.

[6]  E. Snyder,et al.  Reproducibility, bioinformatic analysis and power of the SAGE method to evaluate changes in transcriptome , 2005, Nucleic acids research.

[7]  Jean Cumps,et al.  Improved real-time RT-PCR method for high-throughput measurements using second derivative calculation and double correction. , 2005, BioTechniques.

[8]  J. Morissette,et al.  Effects of dihydrotestosterone on adipose tissue measured by serial analysis of gene expression. , 2004, Journal of molecular endocrinology.

[9]  I. Lindberg,et al.  Biosynthesis of proopiomelanocortin-derived peptides in prohormone convertase 2 and 7B2 null mice. , 2004, Endocrinology.

[10]  R. Kineman,et al.  Role of Glucocorticoids in the Regulation of Pituitary Somatostatin Receptor Subtype (sst1–sst5) mRNA Levels: Evidence for Direct and Somatostatin-Mediated Effects , 2003, Neuroendocrinology.

[11]  Alan Morgan,et al.  Secretory granule exocytosis. , 2003, Physiological reviews.

[12]  E. Savontaus,et al.  Effects of adrenalectomy on AGRP, POMC, NPY and CART gene expression in the basal hypothalamus of fed and fasted rats , 2002, Brain Research.

[13]  C. Mantzoros,et al.  Effects of acute and chronic administration of the melanocortin agonist MTII in mice with diet-induced obesity. , 2002, Diabetes.

[14]  A. Menssen,et al.  Characterization of the c-MYC-regulated transcriptome by SAGE: Identification and analysis of c-MYC target genes , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[15]  B. Hamilton,et al.  Chronic application of MTII in a rat model of obesity results in sustained weight loss. , 2002, Obesity research.

[16]  L. Douyon,et al.  Effect of obesity and starvation on thyroid hormone, growth hormone, and cortisol secretion. , 2002, Endocrinology and metabolism clinics of North America.

[17]  Ji Huang,et al.  [Serial analysis of gene expression]. , 2002, Yi chuan = Hereditas.

[18]  M. Schober,et al.  Identification of differentially expressed genes by serial analysis of gene expression in human prostate cancer. , 2001, Cancer research.

[19]  M. Brennan,et al.  Integrated control of appetite and fat metabolism by the leptin-proopiomelanocortin pathway , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. St-Amand,et al.  Characterization of control and immobilized skeletal muscle: an overview from genetic engineering , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  A. Barkan,et al.  Growth Hormone (GH) Secretion in Primary Adrenal Insufficiency: Effects of Cortisol Withdrawal and Patterned Replacement on GH Pulsatility and Circadian Rhythmicity , 2000, Pituitary.

[22]  J. Roberts,et al.  Adrenalectomy reverses obese phenotype and restores hypothalamic melanocortin tone in leptin-deficient ob/ob mice. , 2000, Diabetes.

[23]  S. Altschul,et al.  SAGEmap: a public gene expression resource. , 2000, Genome research.

[24]  P. Björntorp,et al.  The metabolic syndrome — a neuroendocrine disorder? , 2000, British Journal of Nutrition.

[25]  J. Warrington,et al.  Comparison of human adult and fetal expression and identification of 535 housekeeping/maintenance genes. , 2000, Physiological genomics.

[26]  O. Boss,et al.  Induction of obesity and hyperleptinemia by central glucocorticoid infusion in the rat. , 1999, Diabetes.

[27]  P. Björntorp.  Body fat distribution, insulin resistance, and metabolic diseases. , 1997, Nutrition.

[28]  M. Cancela,et al.  Effect of cell density and growth factors on matrix GLA protein expression by normal rat kidney cells , 1997, Journal of cellular physiology.

[29]  Wei Zhou,et al.  Characterization of the Yeast Transcriptome , 1997, Cell.

[30]  M. Lan,et al.  IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[31]  M. Solimena,et al.  ICA 512, an autoantigen of type I diabetes, is an intrinsic membrane protein of neurosecretory granules. , 1996, The EMBO journal.

[32]  R. Fleischmann,et al.  Initial assessment of human gene diversity and expression patterns based upon 83 million nucleotides of cDNA sequence. , 1995, Nature.

[33]  D. Baer,et al.  Comparison of effects of adrenalectomy and RU-486 in rats given a choice of maintenance diet and fat supplement. , 1995, The American journal of physiology.

[34]  G. Karsenty,et al.  The matrix Gla protein gene is a marker of the chondrogenesis cell lineage during mouse development , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[35]  F. Assimacopoulos-Jeannet,et al.  Involvement of non-esterified fatty acid oxidation in glucocorticoid-induced peripheral insulin resistance in vivo in rats , 1993, Diabetologia.

[36]  D. Withers,et al.  Evidence for neuromedin-B synthesis in the rat anterior pituitary gland. , 1992, Endocrinology.

[37]  J. Polak,et al.  Role of neuromedin B in control of the release of thyrotropin in hypothyroid and hyperthyroid rats. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[38]  N. Seidah,et al.  Distribution and regulation of the prohormone convertases PC1 and PC2 in the rat pituitary. , 1992, Molecular endocrinology.

[39]  D. Steiner,et al.  Kex2-like endoproteases PC2 and PC3 accurately cleave a model prohormone in mammalian cells: evidence for a common core of neuroendocrine processing enzymes. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[40]  N. Seidah,et al.  PC1 and PC2 are proprotein convertases capable of cleaving proopiomelanocortin at distinct pairs of basic residues. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Roy J Martin,et al.  Adrenalectomy decreases neuropeptide Y mRNA levels in the arcuate nucleus , 1990, Brain Research Bulletin.

[42]  R. Dean,et al.  Neuropeptide Y expression in rat brain: Effects of adrenalectomy , 1990, Neuroscience Letters.

[43]  P. Price,et al.  Lung, heart, and kidney express high levels of mRNA for the vitamin K-dependent matrix Gla protein. Implications for the possible functions of matrix Gla protein and for the tissue distribution of the gamma-carboxylase. , 1988, The Journal of biological chemistry.

[44]  T. Castonguay,et al.  Some metabolic and behavioral effects of adrenalectomy on obese Zucker rats. , 1986, The American journal of physiology.

[45]  S. Bloom,et al.  Presence of neuromedin B-like immunoreactivity in the brain and gut of rat and guinea-pig , 1985, Peptides.

[46]  B. M. King,et al.  Hypothalamic obesity after hypophysectomy or adrenalectomy: dependence on corticosterone. , 1985, The American journal of physiology.

[47]  N. Minamino,et al.  Neuromedin B is a major bombesin-like peptide in rat brain: regional distribution of neuromedin B and neuromedin C in rat brain, pituitary and spinal cord. , 1984, Biochemical and biophysical research communications.

[48]  J. Dingman,et al.  Adrenal steroid inhibition of vasopressin release from the neurohypophysis of normal subjects and patients with Addison's disease. , 1960, The Journal of clinical investigation.

[49]  C. Mantzoros,et al.  Responsiveness to peripherally administered melanocortins in lean and obese mice. , 2004, Diabetes.

[50]  F. Rohner-Jeanrenaud,et al.  The leptin-like effects of 3-d peripheral administration of a melanocortin agonist are more marked in genetically obese Zucker (fa/fa) than in lean rats. , 2002, Endocrinology.

[51]  T. Dinan,et al.  Growth hormone secretion: the role of glucocorticoids. , 1994, Life sciences.

[52]  G. Wittert,et al.  Acutely raised corticotropin levels in Addison's disease are not associated with increased plasma arginine vasopressin and corticotropin-releasing factor concentrations in peripheral plasma. , 1993, The Journal of clinical endocrinology and metabolism.

[53]  J. Polak,et al.  Localization of 7B2, neuromedin B, and neuromedin U in specific cell types of rat, mouse, and human pituitary, in rat hypothalamus, and in 30 human pituitary and extrapituitary tumors. , 1988, Endocrinology.